BAJAJ BROKING

Notification
No new Notification messages
Grand Continent Hotels IPO is Open!
Apply for the Grand Continent Hotels IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
parenteral drugs (india) ltd. stock

PARENTERAL DRUGS (INDIA) LTD. Share Price

3.39 0.00 (0.00%)
Aug 21 2023 12:00AM Pharmaceuticals NSE: PARENTLD

PARENTERAL DRUGS (INDIA) LTD. Share Price Update

As of the latest trading session, PARENTERAL DRUGS (INDIA) LTD. share price is currently at 3.39, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 3.08 and 3.39. Over the past year, PARENTERAL DRUGS (INDIA) LTD. has achieved a return of -19.47 %. In the last month alone, the return has been 9.70 %. Read More...

PARENTERAL DRUGS (INDIA) LTD. Performance

Day Range

Low3.08 High3.39
3.39

52 Week Range

Low .00 High 3.39
3.39

PARENTERAL DRUGS (INDIA) LTD. Share Price

524689

PARENTLD

img img img img
No Data Available

Open Price

3.08

Prev. Close

3.39

Volume (Shares)

1250.00

Total traded value

.04

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

PARENTERAL DRUGS (INDIA) LTD. Fundamentals


(Standalone)

Market Cap (Cr) 0.0
PE Ratio (TTM) 0.0
Book Value / Share 0.0
Beta 0.0
ROE 0.0%
EPS (TTM) 0.0
Dividend Yield 0.0%
Net Profit Qtr (Cr) 0.0

PARENTERAL DRUGS (INDIA) LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2022 (Values in Cr)
Revenue 1.77
Operating Expense 34.81
Net Profit 23.81
Net Profit Margin (%) 1345.19
Earnings Per Share (EPS) 7.99
EBITDA 46.36
Effective Tax Rate (%) -23.94
Particulars DEC 2021 (Values in Cr)
Revenue 1.44
Operating Expense 45.68
Net Profit -34.52
Net Profit Margin (%) -2397.22
Earnings Per Share (EPS) -11.58
EBITDA -3.21
Effective Tax Rate (%) 21.93
Particulars SEP 2021 (Values in Cr)
Revenue 2.35
Operating Expense 45.42
Net Profit -33.61
Net Profit Margin (%) -1430.21
Earnings Per Share (EPS) -11.28
EBITDA -3.24
Effective Tax Rate (%) 21.92
Particulars JUN 2021 (Values in Cr)
Revenue 2.93
Operating Expense 44.00
Net Profit -32.04
Net Profit Margin (%) -1093.51
Earnings Per Share (EPS) -10.74
EBITDA -2.61
Effective Tax Rate (%) 21.97
Particulars MAR 2021 (Values in Cr)
Revenue 2.57
Operating Expense 35.96
Net Profit -24.84
Net Profit Margin (%) -966.53
Earnings Per Share (EPS) -8.33
EBITDA 3.42
Effective Tax Rate (%) 25.50
Particulars MAR 2022 (Values in Cr)
Revenue 8.50
Operating Expense 169.91
Net Profit -76.36
Net Profit Margin (%) -898.35
Earnings Per Share (EPS) -25.61
EBITDA 37.27
Effective Tax Rate (%) 30.01
Particulars MAR 2021 (Values in Cr)
Revenue 12.17
Operating Expense 166.71
Net Profit -121.71
Net Profit Margin (%) -1000.08
Earnings Per Share (EPS) -40.82
EBITDA -11.70
Effective Tax Rate (%) 21.20
Particulars MAR 2020 (Values in Cr)
Revenue 31.87
Operating Expense 173.85
Net Profit -114.07
Net Profit Margin (%) -357.92
Earnings Per Share (EPS) -38.26
EBITDA -14.41
Effective Tax Rate (%) 19.51
Particulars MAR 2019 (Values in Cr)
Revenue 32.03
Operating Expense 214.85
Net Profit -147.90
Net Profit Margin (%) -461.75
Earnings Per Share (EPS) -49.61
EBITDA -16.23
Effective Tax Rate (%) 18.46
Particulars MAR 2018 (Values in Cr)
Revenue 32.97
Operating Expense 153.71
Net Profit -96.09
Net Profit Margin (%) -291.44
Earnings Per Share (EPS) -32.24
EBITDA -14.49
Effective Tax Rate (%) 19.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share -264.78
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -96.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share -224.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -45.28
Particulars MAR 2019 (Values in Cr)
Book Value / Share -185.65
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -50.67
Particulars MAR 2018 (Values in Cr)
Book Value / Share -148.33
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.19
Particulars MAR 2017 (Values in Cr)
Book Value / Share -108.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -7.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -264.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -96.14
Particulars MAR 2020 (Values in Cr)
Book Value / Share -224.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -45.28
Particulars MAR 2019 (Values in Cr)
Book Value / Share -185.75
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -48.84
Particulars MAR 2018 (Values in Cr)
Book Value / Share -136.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -43.98
Particulars MAR 2017 (Values in Cr)
Book Value / Share -103.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -61.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 568.20
Total Liabilities 568.20
Total Equity -682.75
Share Outstanding 29816300
Price to Book Ratio -0.01
Return on Assets (%) -21.42
Return on Capital (%) 21.15
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 551.85
Total Liabilities 551.85
Total Equity -561.18
Share Outstanding 29816300
Price to Book Ratio -0.01
Return on Assets (%) -20.67
Return on Capital (%) 25.13
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 540.56
Total Liabilities 540.56
Total Equity -446.79
Share Outstanding 29816300
Price to Book Ratio -0.05
Return on Assets (%) -27.36
Return on Capital (%) 43.87
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 3.54
Total Assets 890.42
Total Liabilities 890.42
Total Equity -136.15
Share Outstanding 29816300
Price to Book Ratio -0.12
Return on Assets (%) -12.55
Return on Capital (%) -24.79
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 913.74
Total Liabilities 913.74
Total Equity -17.16
Share Outstanding 29816300
Price to Book Ratio -0.26
Return on Assets (%) -12.89
Return on Capital (%) -18.44
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 566.79
Total Liabilities 566.79
Total Equity -683.20
Share Outstanding 29816300
Price to Book Ratio -0.01
Return on Assets (%) -21.47
Return on Capital (%) 21.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 550.43
Total Liabilities 550.43
Total Equity -561.63
Share Outstanding 29816300
Price to Book Ratio -0.01
Return on Assets (%) -20.72
Return on Capital (%) 25.05
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 539.15
Total Liabilities 539.15
Total Equity -447.24
Share Outstanding 29816300
Price to Book Ratio -0.05
Return on Assets (%) -27.43
Return on Capital (%) 43.69
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 764.32
Total Liabilities 764.32
Total Equity -107.77
Share Outstanding 29816300
Price to Book Ratio -0.12
Return on Assets (%) -12.57
Return on Capital (%) -26.64
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 0.96
Total Assets 759.83
Total Liabilities 759.83
Total Equity -11.66
Share Outstanding 29816300
Price to Book Ratio -0.26
Return on Assets (%) -15.01
Return on Capital (%) -22.01
Particulars MAR 2021 (Values in Cr)
Net Income -154.47
Cash from Operations 125.32
Cash from Investing 0.06
Cash from Financing -125.43
Net change in Cash -0.05
Free Cash Flow 125.32
Particulars MAR 2020 (Values in Cr)
Net Income -141.73
Cash from Operations 112.36
Cash from Investing 0.07
Cash from Financing -112.42
Net change in Cash 0.01
Free Cash Flow 112.36
Particulars MAR 2019 (Values in Cr)
Net Income -181.39
Cash from Operations 456.05
Cash from Investing 96.57
Cash from Financing -573.59
Net change in Cash 0.01
Free Cash Flow 456.05
Particulars MAR 2015 (Values in Cr)
Net Income -85.95
Cash from Operations 79.90
Cash from Investing 3.05
Cash from Financing -9.86
Net change in Cash -5.15
Free Cash Flow 88.83
Particulars MAR 2014 (Values in Cr)
Net Income -93.99
Cash from Operations -53.53
Cash from Investing 32.55
Cash from Financing 25.38
Net change in Cash -2.25
Free Cash Flow 60.27
Particulars MAR 2021 (Values in Cr)
Net Income -154.47
Cash from Operations 125.32
Cash from Investing 0.06
Cash from Financing -125.43
Net change in Cash -0.05
Free Cash Flow 125.32
Particulars MAR 2020 (Values in Cr)
Net Income -141.73
Cash from Operations 112.36
Cash from Investing 0.07
Cash from Financing -112.43
Net change in Cash 0.01
Free Cash Flow 112.36
Particulars MAR 2019 (Values in Cr)
Net Income -181.39
Cash from Operations 455.78
Cash from Investing 0.09
Cash from Financing -455.79
Net change in Cash 0.08
Free Cash Flow 455.78
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.73 19.75 2.00 281.47 34.11 / 77.70
BLISS GVS PHARMA LTD 120.85 15.84 1.26 1273.40 92.25 / 184.95
CIPLA LTD 1513.05 24.49 4.30 122196.18 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 251.25 20.82 2.54 739.45 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.73 22.13 6.24 281.47 34.11 / 77.70
AMRUTAJAN HEALTH LTD 630.50 36.96 6.12 1822.82 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8391.50 125.15 30.88 20978.75 4050.15 / 8869.70
BLISS GVS PHARMA LTD 120.85 15.69 1.24 1273.40 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0
PIVOT
First Resistance 0.0
Second Resistance 0.0
Third Resistance 0.0
First Support 0.0
Second Support 0.0
Third Support 0.0
RSI 0.0
MACD 0.0
Commodity Channel Index (CCI) 0.0
ADX 0.0
Williams % R 0.0

Over 1 Month

down

9.70

Over 3 Months

down

-15.67

Over 6 Months

down

-25.65

Over 1 Year

down

-19.47

Over 3 Years

down

8.96

Over 5 Years

down

-19.83

PARENTERAL DRUGS (INDIA) LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PARENTERAL DRUGS (INDIA) LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
26.7
Promoter Holdings
73.28
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
94.5
Name Category Shares Shares%
Mvg Mercantile Private Limited Shareholding of Promoter and Promoter Group 9722966.0 32.61
Rajratan Exports Private Limited Shareholding of Promoter and Promoter Group 6666665.0 22.36
Pdpl Holdings Private Limited Shareholding of Promoter and Promoter Group 3217120.0 10.79
Mahaganpati Investment Private Limited Shareholding of Promoter and Promoter Group 1600000.0 5.37
Pdpl Securities Private Limited Shareholding of Promoter and Promoter Group 611506.0 2.05
Shitiz Sehgal Public Shareholding 417000.0 1.4
Amax Network Pvt Ltd Public Shareholding 400000.0 1.34
Parenteral Commercial Services Private Limited Shareholding of Promoter and Promoter Group 30986.0 0.1
Mr Anil Mittal Shareholding of Promoter and Promoter Group 1600.0 0.01
Mr. Anil Mittal Shareholding of Promoter and Promoter Group 266.0 0.0

PARENTERAL DRUGS (INDIA) LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2010-09-13 2.0 Final 2010-09-15 Equity shares 2009-12-23 1.5 Final 2009-12-25 Equity shares 2008-09-24 1.5 Final 2008-09-26 Equity shares 2007-09-21 1.5 Final 2007-09-25 Equity shares
Ex-Date Ex-Bonus Ratio
2010-09-15 2010-09-13 1:3 2007-11-05 2007-11-02 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About PARENTERAL DRUGS (INDIA) LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PARENTERAL DRUGS (INDIA) LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Parenteral Drugs (India) Ltd?

Answer Field

The share price of Parenteral Drugs (India) Ltd for NSE is ₹ 2.90 and for BSE is ₹ 3.39.

What is the Market Cap of Parenteral Drugs (India) Ltd?

Answer Field

The market cap of Parenteral Drugs (India) Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Parenteral Drugs (India) Ltd?

Answer Field

The 52 Week High and Low of Parenteral Drugs (India) Ltd for NSE is ₹ 2.90 and ₹ 0.00 and for BSE is ₹ 3.39 and ₹ 0.00.

How to Buy Parenteral Drugs (India) Ltd share?

Answer Field

You can trade in Parenteral Drugs (India) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Parenteral Drugs (India) Ltd?

Answer Field

The 1 year returns on the stock has been -19.47%.

What is the Current Share Price of Parenteral Drugs (India) Ltd?

Answer Field

Parenteral Drugs (India) Ltd share price is for NSE ₹ 2.90 & for BSE ₹ 3.39 as on Aug 21 2023 12:00AM.

What is the Market Cap of Parenteral Drugs (India) Ltd Share?

Answer Field

The market cap of Parenteral Drugs (India) Ltd for NSE ₹ 0.0 & for BSE ₹ 0.0 as on Aug 21 2023 12:00AM.

What is the P/E Ratio of Parenteral Drugs (India) Ltd Share?

Answer Field

As on Aug 21 2023 12:00AM the price-to-earnings (PE) ratio for Parenteral Drugs (India) Ltd share is 0.0.

What is the PB ratio of Parenteral Drugs (India) Ltd Share?

Answer Field

As on Aug 21 2023 12:00AM, the price-to-book (PB) ratio for Parenteral Drugs (India) Ltd share is 0.0.

How to Buy Parenteral Drugs (India) Ltd Share?

Answer Field

You can trade in Parenteral Drugs (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parenteral Drugs (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Parenteral Drugs (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parenteral Drugs (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
loader